​

Mineralys Therapeutics (MLYS) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChartTranscripts

Mineralys Therapeutics Revenue Highlights

00

Mineralys Therapeutics Revenue by Period

Mineralys Therapeutics Revenue by Year

DateRevenueChange
2024-12-31-100.00%
2023-12-31-100.00%
2022-12-31-100.00%
2021-12-31-100.00%
2020-12-31--

Mineralys Therapeutics generated - in revenue during NA 2024, up 100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.

Mineralys Therapeutics Revenue by Quarter

DateRevenueChange
2025-06-30-100.00%
2025-03-31--100.00%
2024-12-31$34.00K100.00%
2024-09-30-100.00%
2024-06-30-100.00%
2024-03-31-100.00%
2023-12-31-100.00%
2023-09-30-100.00%
2023-06-30-100.00%
2023-03-31-100.00%
2022-12-31-100.00%
2022-09-30-100.00%
2022-06-30-100.00%
2022-03-31-100.00%
2021-12-31--

Mineralys Therapeutics generated - in revenue during Q2 2025, up 100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.

Mineralys Therapeutics Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
APLSApellis Pharmaceuticals$709.95M$171.39M
RXRXRecursion Pharmaceuticals$58.84M$19.22M
CDTXCidara Therapeutics$1.27M-
XENEXenon Pharmaceuticals-$7.50M
NTLAIntellia Therapeutics-$16.63M
IMVTImmunovant--
APGEApogee Therapeutics--
CNTACentessa Pharmaceuticals-$15.00M
MLYSMineralys Therapeutics--
SRRKScholar Rock--
BEAMBeam Therapeutics--

MLYS Revenue FAQ

What is Mineralys Therapeutics’s yearly revenue?

Mineralys Therapeutics's yearly revenue for 2024 was $0, representing an increase of 100.00% compared to 2023. The company's yearly revenue for 2023 was $0, representing an increase of 100.00% compared to 2022. MLYS's yearly revenue for 2022 was $0, representing an increase of 100.00% compared to 2021.

What is Mineralys Therapeutics’s quarterly revenue?

Mineralys Therapeutics's quarterly revenue for Q2 2025 was $0, a 100.00% increase from the previous quarter (Q1 2025), and a 0% increase year-over-year (Q2 2024). The company's quarterly revenue for Q1 2025 was $0, a -100.00% decrease from the previous quarter (Q4 2024), and a 0% increase year-over-year (Q1 2024). MLYS's quarterly revenue for Q4 2024 was $34K, a 100.00% increase from the previous quarter (Q3 2024), and a 0% increase year-over-year (Q4 2023).

What is Mineralys Therapeutics’s revenue growth rate?

Mineralys Therapeutics's revenue growth rate for the last 3 years (2022-2024) was 0%, and for the last 5 years (2020-2024) was 0%.